Epicrispr Biotechnologies at a glance
As of- [1] Equity raised: Sum of the 1 sourced equity round in the funding history below (debt, tender offers and rumored rounds excluded), August 11, 2026
- [2] Lead investors: Epicrispr Biotechnologies, August 11, 2026
Is something wrong on this page?
Funding history
1 equity event · newest first · sources dated per row| Date | Round | Amount | Valuation | Lead investors | Source |
|---|---|---|---|---|---|
| Aug 11, 2026 | Series C | $90M | — | Janus Henderson Investorsunverified WithFidelity InvestmentsunverifiedCormorant Asset ManagementunverifiedSanofi VenturesunverifiedOctagon Capital | Epicrispr Biotechnologies |
Equity only. “Equity raised” above sums the rounds with a dated, linked source; rumored rounds, tender offers and secondary sales are listed but not counted, and debt financing is listed separately.
Investors
Related Companies
Epicrispr Biotechnologies FAQ
How much has Epicrispr Biotechnologies raised?
Epicrispr Biotechnologies has raised at least $90M in equity across 1 sourced funding round tracked by Value Add VC. The most recent was a $90M Series C in August 2026, reported by Epicrispr Biotechnologies. Debt financing, tender offers and secondary sales are not counted.
Who invested in Epicrispr Biotechnologies?
Lead investors in Epicrispr Biotechnologies's sourced funding rounds include Janus Henderson Investors. Per round: its August 2026 Series C was led by Janus Henderson Investors.
Sources & methodologyshow
- Epicrispr BiotechnologiesValue Add VC data1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.